Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, ...
CVS Health (CVS) stock jumps 9% after beating Q4 revenue & earnings forecasts thanks mainly to its Health Care Benefits and ...
The Associated Press on MSN11d
CVS Health steers through rising insurance costs in a strong fourth quarterCVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
Principal Securities Inc. grew its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.2% during the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results